Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Parkinson Disease 4, Autosomal Dominant Lewy Body 4Small Cell Lung Carcinoma 3Carcinoma 3Urothelial Cancer 2Triple Negative Breast Neoplasms 2Neoplasm Metastasis 2Endometrial Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Recurrence 1Ovarian Neoplasms 1Oligodendroglioma 1Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1Non Small Cell Lung Cancer NSCLC 1Neurocytoma 1Neoplasms 1Nasopharyngeal Carcinoma 1Metastatic Urothelial Cancer 1Mesothelioma 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Ganglioneuroma 1Ganglioglioma 1

Interventions

olaparib 4Bevacizumab 3niraparib 2defactinib 2Paclitaxel 2Immunoglobulin G 2Disulfides 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1sodium thiosulfate 1sapanisertib 1rucaparib 1relatlimab 1relacorilant 1pertuzumab 1pembrolizumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1entrectinib 1durvalumab 1dabrafenib 1copanlisib 1capivasertib 1binimetinib 1adavosertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Ovarian Neoplasms × Carboplatin × Clear all
NCT00262847 2019-07-23

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

National Cancer Institute (NCI)

Phase 3 Completed
1,873 enrolled 17 charts 1 FDA
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡